Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1132 issues

Renewing Symdeko/Symkevi Coverage with Blue Cross Blue Shield in Ohio: Complete Timeline and Documentation Guide

Answer Box: Renewing Symdeko/Symkevi Coverage in Ohio To renew Symdeko/Symkevi (tezacaftor/ivacaftor) coverage with Blue Cross Blue Shield Ohio, submit your renewal request 30 days before your current authorization expires. Required documents include updated CF specialist notes, current pulmonary function tests (FEV1), liver function labs, and evidence of

The Requirements Checklist to Get Kuvan (Sapropterin) Covered by Blue Cross Blue Shield in New Jersey: Forms, Appeals, and Success Strategies

Answer Box: Getting Kuvan Covered by Blue Cross Blue Shield in New Jersey Eligibility: Patients with confirmed PKU and elevated phenylalanine levels (>360 µmol/L) can get Kuvan covered by Blue Cross Blue Shield in New Jersey through prior authorization. Fastest path: 1) Gather PKU diagnosis, recent labs, and

The Requirements Checklist to Get Mepsevii (vestronidase alfa-vjbk) Covered by Blue Cross Blue Shield in New York

Answer Box: Getting Mepsevii Covered by Blue Cross Blue Shield in New York Blue Cross Blue Shield in New York requires prior authorization for Mepsevii (vestronidase alfa-vjbk) with strict documentation requirements. Success depends on confirmed MPS VII diagnosis via enzyme assay and genetic testing, specialist prescription from a metabolic disease

How to Get Tegsedi (Inotersen) Covered by Blue Cross Blue Shield in Washington: Complete Guide with Forms and Appeals

Answer Box: Getting Tegsedi Covered by Blue Cross Blue Shield in Washington Blue Cross Blue Shield (BCBS) in Washington requires prior authorization for Tegsedi (inotersen), typically requiring patients to first try preferred alternatives like Onpattro (patisiran) or Amvuttra (vutrisiran) unless contraindicated. To get Tegsedi approved: 1. Document hATTR diagnosis with

Getting Zokinvy (Lonafarnib) Approved by Blue Cross Blue Shield in Illinois: Complete Guide to Prior Authorization and Appeals

Answer Box: Get Zokinvy Covered by BCBS Illinois Blue Cross Blue Shield of Illinois requires prior authorization for Zokinvy (lonafarnib) with specific documentation: genetic confirmation of HGPS, patient ≥12 months old with BSA ≥0.39 m², and prescription by a geneticist or pediatric cardiologist. Submit through the BCBS provider portal

Blue Cross Blue Shield Illinois Coverage Criteria for Nucala (Mepolizumab): What Counts as "Medically Necessary"?

Quick Answer: Getting Nucala Covered by Blue Cross Blue Shield in Illinois Blue Cross Blue Shield of Illinois requires prior authorization for Nucala with specific medical necessity criteria: blood eosinophil count ≥150 cells/μL (recent) or ≥300 cells/μL (past year), documented severe eosinophilic asthma despite 3+ months of high-dose

How to Get Pemazyre (Pemigatinib) Covered by Blue Cross Blue Shield in North Carolina: Complete Guide with Forms, Appeals, and State Rights

Quick Answer: Getting Pemazyre Approved in North Carolina Pemazyre (pemigatinib) requires prior authorization from Blue Cross Blue Shield of North Carolina for FGFR2+ cholangiocarcinoma or FGFR1+ myeloid/lymphoid neoplasms. Your fastest path: submit PA with molecular testing proof, prior therapy documentation, and medical necessity letter through the BCBSNC provider portal.

Do You Qualify for Tysabri (natalizumab) Coverage by Blue Cross Blue Shield in New York? Complete Decision Tree & Appeals Guide

Answer Box: Tysabri Coverage by BCBS in New York Yes, you likely qualify for Tysabri (natalizumab) coverage by Blue Cross Blue Shield in New York if: you have relapsing multiple sclerosis with documented disease activity, have tried/failed at least one other DMT, and can complete the required TOUCH program

How to Get Qalsody (tofersen) Covered by Blue Cross Blue Shield of Georgia: Complete Prior Authorization Guide with Appeals and State Protections

Answer Box: Getting Qalsody (tofersen) Covered by Blue Cross Blue Shield of Georgia Blue Cross Blue Shield of Georgia (Anthem) covers Qalsody (tofersen) for adults with confirmed SOD1 mutation ALS through prior authorization. The fastest path to approval requires: (1) genetic test confirming SOD1 mutation, (2) neurologist documentation of ALS

Myths vs. Facts: Getting Eylea and Lucentis Covered by Blue Cross Blue Shield in North Carolina

Answer Box: Getting Eylea/Lucentis Covered by Blue Cross Blue Shield in North Carolina Eligibility: Blue Cross Blue Shield of North Carolina covers Eylea and Lucentis for FDA-approved conditions (wet AMD, diabetic macular edema, retinal vein occlusion) with prior authorization. Fastest path: Try bevacizumab first unless contraindicated, then submit PA